• Issue

    Arthritis & Rheumatism: Volume 62, Issue 1

    1-306
    January 2010
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

In This Issue

In this issue

  • First Published: 28 December 2009

Editorials

Good and bad memories following rituximab therapy

E. William St.Clair, 
  • Pages: 1-5
  • First Published: 28 December 2009

Emerging from the shadows: Follicular helper T cells in autoimmunity

Leah D. DiPlacido,  Joe Craft, 
  • Pages: 6-8
  • First Published: 28 December 2009

Review

Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: A data-driven review

Paul A. Monach,  Lindsay M. Arnold,  Peter A. Merkel, 
  • Pages: 9-21
  • First Published: 28 December 2009

Rheumatoid Arthritis Clinical Studies

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry

Merete Lund Hetland,  Ib Jarle Christensen,  Ulrik Tarp,  Lene Dreyer,  Annette Hansen,  Ib Tønder Hansen,  Gina Kollerup,  Louise Linde,  Hanne M. Lindegaard,  Uta Engling Poulsen,  Annette Schlemmer,  Dorte Vendelbo Jensen,  Signe Jensen,  Gisela Hostenkamp,  Mikkel ØStergaard, 
  • Pages: 22-32
  • First Published: 28 December 2009

Rapid and sustained improvement in bone and cartilage turnover markers with the anti–interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone†

Patrick Garnero,  Elizabeth Thompson,  Thasia Woodworth,  Josef S. Smolen, 
  • Pages: 33-43
  • First Published: 28 December 2009

Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients†

Omri Snir,  Mona Widhe,  Monika Hermansson,  Caroline von Spee,  Johan Lindberg,  Sanne Hensen,  Karin Lundberg,  Åke Engström,  Patrick J. W. Venables,  René E. M. Toes,  Rikard Holmdahl,  Lars Klareskog,  Vivianne Malmström, 
  • Pages: 44-52
  • First Published: 28 December 2009

Novel role of plasmacytoid dendritic cells in humans: Induction of interleukin-10–producing treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy

Melina Kavousanaki,  Antonis Makrigiannakis,  Dimitrios Boumpas,  Panayotis Verginis, 
  • Pages: 53-63
  • First Published: 28 December 2009

Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial†

Clifton O. Bingham III,  R. John Looney,  Atul Deodhar,  Neal Halsey,  Maria Greenwald,  Christine Codding,  Benjamin Trzaskoma,  Flavius Martin,  Sunil Agarwal,  Ariella Kelman, 
  • Pages: 64-74
  • First Published: 28 December 2009

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab†

Sander van Assen,  Albert Holvast,  Cornelis A. Benne,  Marcel D. Posthumus,  Miek A. van Leeuwen,  Alexandre E. Voskuyl,  Marlies Blom,  Anke P. Risselada,  Aalzen de Haan,  Johanna Westra,  Cees G. M. Kallenberg,  Marc Bijl, 
  • Pages: 75-81
  • First Published: 28 December 2009

Inhibition of NF-κB signaling by fasudil as a potential therapeutic strategy for rheumatoid arthritis

Hiroshi Okamoto,  Taku Yoshio,  Hirotaka Kaneko,  Hisashi Yamanaka, 
  • Pages: 82-92
  • First Published: 28 December 2009

Rheumatoid Arthritis Basic Science Studies

Functional autoantibodies against serpin E2 in rheumatoid arthritis

H. Maciejewska-Rodrigues,  M. Al-Shamisi,  H. Hemmatazad,  C. Ospelt,  M. C. Bouton,  D. Jäger,  A. P. Cope,  P. Charles,  D. Plant,  J. H. W. Distler,  R. E. Gay,  B. A. Michel,  A. Knuth,  M. Neidhart,  S. Gay,  A. Jüngel, 
  • Pages: 93-104
  • First Published: 28 December 2009

Involvement of MAPKs and NF-κB in tumor necrosis factor α–induced vascular cell adhesion molecule 1 expression in human rheumatoid arthritis synovial fibroblasts

Shue-Fen Luo,  Rou-Yi Fang,  Hsi-Lung Hsieh,  Pei-Ling Chi,  Chih-Chung Lin,  Li-Der Hsiao,  Chi-Chuan Wu,  Jong-Shyan Wang,  Chuen-Mao Yang, 
  • Pages: 105-116
  • First Published: 28 December 2009

Identification of citrullinated vimentin peptides as T cell epitopes in HLA–DR4–positive patients with rheumatoid arthritis

Anouk L. Feitsma,  Ellen I. H. van der Voort,  Kees L. M. C. Franken,  Hanane El Bannoudi,  Berendina G. Elferink,  Jan W. Drijfhout,  Tom W. J. Huizinga,  René R. P. de Vries,  René E. M. Toes,  A. Ioan-Facsinay, 
  • Pages: 117-125
  • First Published: 28 December 2009

Rheumatoid arthritis–specific autoantibodies to peptidyl arginine deiminase type 4 inhibit citrullination of fibrinogen

Isabelle Auger,  Marielle Martin,  Nathalie Balandraud,  Jean Roudier, 
  • Pages: 126-131
  • First Published: 28 December 2009

1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis

E. M. Colin,  P. S. Asmawidjaja,  J. P. van Hamburg,  A. M. C. Mus,  M. van Driel,  J. M. W. Hazes,  J. P. T. M. van Leeuwen,  E. Lubberts, 
  • Pages: 132-142
  • First Published: 28 December 2009

Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis

Alexei von Delwig,  James Locke,  John H. Robinson,  Wan-Fai Ng, 
  • Pages: 143-149
  • First Published: 28 December 2009

Arthritis & Rheumatism 2009 Abstract Supplement Available Online

Arthritis & Rheumatism 2009 Abstract Supplement Available Online

  • Page: 149
  • First Published: 28 December 2009

Spondylitis

Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis

Dimitrios Daoussis,  Stamatis-Nick C. Liossis,  Elena E. Solomou,  Anastasia Tsanaktsi,  Konstadina Bounia,  Maria Karampetsou,  Georgios Yiannopoulos,  Andrew P. Andonopoulos, 
  • Pages: 150-158
  • First Published: 28 December 2009

Experimental Arthritis

Inhibition of synovial hyperplasia, rheumatoid T cell activation, and experimental arthritis in mice by sulforaphane, a naturally occurring isothiocyanate

Jin-Sun Kong,  Seung-Ah Yoo,  Hyun-Sook Kim,  Hyun Ah Kim,  Kyungmoo Yea,  Sung-Ho Ryu,  Yeun-Jun Chung,  Chul-Soo Cho,  Wan-Uk Kim, 
  • Pages: 159-170
  • First Published: 28 December 2009

ANTI-CD3 therapy expands the numbers of CD4+ and CD8+ treg cells and induces sustained amelioration of collagen-induced arthritis

Clare A. Notley,  Fiona E. McCann,  Julia J. Inglis,  Richard O. Williams, 
  • Pages: 171-178
  • First Published: 28 December 2009

Bone Biology

Anti–neuropilin-1 peptide inhibition of synoviocyte survival, angiogenesis, and experimental arthritis

Jin-Sun Kong,  Seung-Ah Yoo,  Jung-Wook Kim,  Seung-Pil Yang,  Chi-Bom Chae,  Valeria Tarallo,  Sandro De Falco,  Sung-Ho Ryu,  Chul-Soo Cho,  Wan-Uk Kim, 
  • Pages: 179-190
  • First Published: 28 December 2009

Cartilage Biology

Rho kinase–dependent activation of SOX9 in chondrocytes

Dominik R. Haudenschild,  Jianfen Chen,  Nina Pang,  Martin K. Lotz,  Darryl D. D'Lima, 
  • Pages: 191-200
  • First Published: 28 December 2009

Search for Next Editor

Search for Next Editor, Arthritis Care & Research (2011–2016 term)

  • Page: 200
  • First Published: 28 December 2009

Systemic Lupus Erythematosus

Effect of long-term belimumab treatment on b cells in systemic lupus erythematosus: Extension of a phase II, double-blind, placebo-controlled, dose-ranging study†

Annett M. Jacobi,  Weiqing Huang,  Tao Wang,  William Freimuth,  Inaki Sanz,  Richard Furie,  Meggan Mackay,  Cynthia Aranow,  Betty Diamond,  Anne Davidson, 
  • Pages: 201-210
  • First Published: 28 December 2009

Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: Findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial†

Ellen M. Ginzler,  David Wofsy,  David Isenberg,  Caroline Gordon,  Laura Lisk,  Mary-Anne Dooley, 
  • Pages: 211-221
  • First Published: 28 December 2009

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial†

Joan T. Merrill,  C. Michael Neuwelt,  Daniel J. Wallace,  Joseph C. Shanahan,  Kevin M. Latinis,  James C. Oates,  Tammy O. Utset,  Caroline Gordon,  David A. Isenberg,  Hsin-Ju Hsieh,  David Zhang,  Paul G. Brunetta, 
  • Pages: 222-233
  • First Published: 28 December 2009

Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus

Nicholas Simpson,  Paul A. Gatenby,  Anastasia Wilson,  Shreya Malik,  David A. Fulcher,  Stuart G. Tangye,  Harinder Manku,  Timothy J. Vyse,  Giovanna Roncador,  Gavin A. Huttley,  Christopher C. Goodnow,  Carola G. Vinuesa,  Matthew C. Cook, 
  • Pages: 234-244
  • First Published: 28 December 2009
Open Access

Lack of effect of a single injection of human C-reactive protein on murine lupus or nephrotoxic nephritis

Francesco Carlucci,  H. Terence Cook,  Abhilok Garg,  Mark B. Pepys,  Marina Botto, 
  • Pages: 245-249
  • First Published: 28 December 2009

Childhood Arthritis

Thalidomide dramatically improves the symptoms of early-onset Sarcoidosis/Blau syndrome: Its possible action and mechanism

Kozo Yasui,  Masato Yashiro,  Mitsuru Tsuge,  Akira Manki,  Kei Takemoto,  Michiko Yamamoto,  Tsuneo Morishima, 
  • Pages: 250-257
  • First Published: 28 December 2009

Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome

Bénédicte Neven,  Isabelle Marvillet,  Celine Terrada,  Alice Ferster,  Nathalie Boddaert,  Vincent Couloignier,  Graziella Pinto,  Anne Pagnier,  Christine Bodemer,  Bahram Bodaghi,  Marc Tardieu,  Anne Marie Prieur,  Pierre Quartier, 
  • Pages: 258-267
  • First Published: 28 December 2009

Myositis

Muscle resident macrophages control the immune cell reaction in a mouse model of notexin-induced myoinjury

Madly Brigitte,  Clementine Schilte,  Anne Plonquet,  Yasmine Baba-Amer,  Adeline Henri,  Caroline Charlier,  Shahragim Tajbakhsh,  Matthew Albert,  Romain K. Gherardi,  Fabrice Chrétien, 
  • Pages: 268-279
  • First Published: 28 December 2009

Systemic Sclerosis

The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis

Nicole Reich,  Britta Maurer,  Alfiya Akhmetshina,  Paulius Venalis,  Clara Dees,  Pawel Zerr,  Katrin Palumbo,  Jochen Zwerina,  Tatiana Nevskaya,  Steffen Gay,  Oliver Distler,  Georg Schett,  Jörg H. W. Distler, 
  • Pages: 280-290
  • First Published: 28 December 2009

Clinical Images

Clinical images: Gastric antral vascular ectasia in systemic sclerosis

Rene Thonhofer MD,  Cornelia Siegel MD,  Markus Trummer MD,  Alexander Gugl MD, 
  • Page: 290
  • First Published: 28 December 2009

Fibromyalgia

Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: Results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study†

Oliver Distler,  Wolfgang Eich,  Eva Dokoupilova,  Zdenek Dvorak,  Martin Fleck,  Markus Gaubitz,  Manfred Hechler,  Jan-Peter Jansen,  Andreas Krause,  Martin Bendszus,  Lothar Pache,  Rudolf Reiter,  Ulf Müller-Ladner, 
  • Pages: 291-300
  • First Published: 28 December 2009

Letters

Human nucleus pulposus cell cultures and disc degeneration grading systems: Comment on the article by Le Maitre et al

Hai-Qiang Wang MD, PhD,  Xiao-Dong Yu MD, PhD,  Zhi-Heng Liu MD,  Xin-Kui Li MD,  Zhuo-Jing Luo MD, PhD, 
  • Pages: 301-302
  • First Published: 28 December 2009

Statin treatment of rheumatoid arthritis: Comment on the editorial by Ridker and Solomon

Mike J. L. Peters MD, PhD,  Michael T. Nurmohamed MD, PhD,  George D. Kitas MD, PhD, FRCP,  Naveed Sattar MD, PhD, 
  • Pages: 302-303
  • First Published: 28 December 2009

Somatic mutations and anti–mutated citrullinated vimentin antibodies in rheumatoid arthritis: Comment on the editorial by Levesque et al

Gary S. Firestein MD, 
  • Pages: 303-304
  • First Published: 28 December 2009

The tidemark of cartilage as a potential target of the rheumatoid response: Comment on the editorial by Suber and Rosen

Peter A. Simkin MD, 
  • Pages: 304-305
  • First Published: 28 December 2009

Reply to letter by Priori et al commenting on whether Behçet's syndrome patients with acne and arthritis comprise a true subset

Gülen Hatemi MD,  Izzet Fresko MD,  Sebahattin Yurdakul MD,  Huri Ozdogan MD,  Hasan Yazici MD,  Enger Altiok MD, PhD,  Güven Yenmis PhD, 
  • Pages: 305-306
  • First Published: 28 December 2009

ACR Announcements

ACR announcements

  • First Published: 28 December 2009